adairАллергология и Иммунология в ПедиатрииAllergology and Immunology in Paediatrics2500-11752712-7958Ассоциация детских аллергологов и иммунологов России10.53529/2500-1175-2023-1-35-38adair-33Research ArticleКРАТКИЕ СООБЩЕНИЯ И ПИСЬМА В РЕДАКЦИЮ. ПО СЛЕДАМ V ВСЕРОССИЙСКОГО СЪЕЗДА АССОЦИАЦИИ ДЕТСКИХ АЛЛЕРГОЛОГОВ И ИММУНОЛОГОВ РОССИИ (АДАИР)COMMUNICATIONS AND CORRESPONDENCE. FOLLOWING THE V ALL-RUSSIAN CONGRESS OF THE ASSOCIATION OF PEDIATRIC ALLERGOLOGISTS AND IMMUNOLOGISTS OF RUSSIA (APAIR)Скрининговая диагностика первичных иммунодефицитов в практике врача аллерголога-иммунологаScreening diagnosis of primary immunodeficiencies in the practice of an allergist-immunologistБарычеваЛ. Ю.BarychevaL. Y.

355002, г. Ставрополь, ул. Мира, 310

355002, Stavropol, Mira st., 310

ХачироваЛ. С.KhachirovaL. S.

355002, г. Ставрополь, ул. Мира, 310

355002, Stavropol, Mira st., 310

ФирсоваВ. А.FirsovaV. A.

355002, г. Ставрополь, ул. Мира, 310

355002, Stavropol, Mira st., 310

ФарсиянцС. Ю.FarsijancS. J.

355002, г. Ставрополь, ул. Мира, 310

355002, Stavropol, Mira st., 310

Ставропольский государственный медицинский университетРоссияStavropol State Medical UniversityRussian Federation202310042023013538Copyright © Барычева Л.Ю., Хачирова Л.С., Фирсова В.А., Фарсиянц С.Ю., 20232023Барычева Л.Ю., Хачирова Л.С., Фирсова В.А., Фарсиянц С.Ю.Barycheva L.Y., Khachirova L.S., Firsova V.A., Farsijanc S.J.This work is licensed under a Creative Commons Attribution 4.0 License.https://adair.elpub.ru/jour/article/view/33

.

.

врожденные иммунодефицитыTRECKRECprimary immunodeficienciesTRECKRECReferencesKwan A, Puck JM. History and current status of newborn screening for severe combined immunodeficiency. Sem in Perinatol. 2015; 39 (3): 194–205. https://doi.org/10.1053/j.semperi.2015.03.004.Kwan A, Puck JM. History and current status of newborn screening for severe combined immunodeficiency. Sem in Perinatol. 2015; 39 (3): 194–205. https://doi.org/10.1053/j.semperi.2015.03.004.Kwan A, Abraham RS, Currier R, Brower A, Andruszewski K, Abbott JK et al. Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA. 2014; 312: 729–738. https://doi.org/10.1001/jama.2014.9132.Kwan A, Abraham RS, Currier R, Brower A, Andruszewski K, Abbott JK et al. Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA. 2014; 312: 729–738. https://doi.org/10.1001/jama.2014.9132.Bloom M, Bredius RGM, Weijman G, Dekkers EHBM, Kemper EA, van den Akker-van Marle ME et al. Introducing Newborn Screening for Severe Combined Immunodeficiency (SCID) in the Dutch Neonatal Screening. Program Int. J. Neonatal Screen. 2018; 4 (4): 40. https://doi.org/10.3390/ijns4040040.Bloom M, Bredius RGM, Weijman G, Dekkers EHBM, Kemper EA, van den Akker-van Marle ME et al. Introducing Newborn Screening for Severe Combined Immunodeficiency (SCID) in the Dutch Neonatal Screening. Program Int. J. Neonatal Screen. 2018; 4 (4): 40. https://doi.org/10.3390/ijns4040040.Barbaro M, Ohlsson A, Borte S, Jonsson S, Zetterström RH, King J et al. Newborn Screening for Severe Primary Immunodeficiency Diseases in Sweden — a 2-Year Pilot TREC and KREC Screening Study. J Clin Immunol. 2017; 37 (1): 51–60. https://doi.org/10.1007/s10875-016-0347-5.Barbaro M, Ohlsson A, Borte S, Jonsson S, Zetterström RH, King J et al. Newborn Screening for Severe Primary Immunodeficiency Diseases in Sweden — a 2-Year Pilot TREC and KREC Screening Study. J Clin Immunol. 2017; 37 (1): 51–60. https://doi.org/10.1007/s10875-016-0347-5.Modell V, Orange JS, Quinn J, Modell F. Global report on primary immunodeficiencies: 2018 update from the Jeffrey Modell Centers Network on disease classification, regional trends, treatment modalities, and physician reported outcomes. Immunol Res. 2018; 66 (3): 367–380. https://doi.org/10.1007/s12026-018-8996-5.Modell V, Orange JS, Quinn J, Modell F. Global report on primary immunodeficiencies: 2018 update from the Jeffrey Modell Centers Network on disease classification, regional trends, treatment modalities, and physician reported outcomes. Immunol Res. 2018; 66 (3): 367–380. https://doi.org/10.1007/s12026-018-8996-5.

The authors declare that there are no conflicts of interest present.